Unilever (NYSE: UL) and DS Healthcare Group (OTCMKTS:DSKX) are both non-cyclical consumer goods & services companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Institutional & Insider Ownership

7.1% of Unilever shares are owned by institutional investors. Comparatively, 0.0% of DS Healthcare Group shares are owned by institutional investors. 1.0% of Unilever shares are owned by company insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Unilever and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Unilever N/A N/A N/A
DS Healthcare Group -62.31% -1,304.25% -117.85%

Earnings and Valuation

This table compares Unilever and DS Healthcare Group’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Unilever $58.34 billion 1.15 $5.74 billion $2.47 22.07
DS Healthcare Group $12.95 million 0.01 -$6.93 million ($0.28) -0.02

Unilever has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Unilever, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Unilever and DS Healthcare Group, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Unilever 3 5 2 0 1.90
DS Healthcare Group 0 0 0 0 N/A

Unilever currently has a consensus price target of $26.00, indicating a potential downside of 52.31%. Given Unilever’s higher probable upside, analysts plainly believe Unilever is more favorable than DS Healthcare Group.

Risk and Volatility

Unilever has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500.

Dividends

Unilever pays an annual dividend of $1.67 per share and has a dividend yield of 3.1%. DS Healthcare Group does not pay a dividend. Unilever pays out 67.6% of its earnings in the form of a dividend. DS Healthcare Group has raised its dividend for 2 consecutive years.

Summary

Unilever beats DS Healthcare Group on 13 of the 16 factors compared between the two stocks.

About Unilever

Unilever PLC is a fast-moving consumer goods (FMCG) company. The Company’s segments include Personal Care, which primarily includes sales of skin care and hair care products, deodorants and oral care products; Foods, which primarily includes sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads; Home Care, which primarily includes sales of home care products, such as powders, liquids and capsules, soap bars and a range of cleaning products, and Refreshment, which primarily includes sales of ice cream and tea-based beverages. The Company’s geographical segments include Asia/AMET/RUB, The Americas and Europe. Its brands include Axe, Dirt is Good (Omo), Dove, Family Goodness (Rama), Heartbrand (Wall’s), Hellmann’s, Knorr, Lipton, Lux, Magnum, Rexona, Sunsilk and Surf. The Company operates in more than 100 countries, selling its products in more than 190 countries. The Company operates approximately 310 factories in over 70 countries.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Unilever Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilever and related companies with MarketBeat.com's FREE daily email newsletter.